These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32496217)

  • 41. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
    Li Z; Xin W; Wang Q; Zhu M; Zhou H
    Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
    Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity.
    Eadsforth TC; Pinto A; Luciani R; Tamborini L; Cullia G; De Micheli C; Marinelli L; Cosconati S; Novellino E; Lo Presti L; Cordeiro da Silva A; Conti P; Hunter WN; Costi MP
    J Med Chem; 2015 Oct; 58(20):7938-48. PubMed ID: 26322631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
    Ott R; Chibale K; Anderson S; Chipeleme A; Chaudhuri M; Guerrah A; Colowick N; Hill GC
    Acta Trop; 2006 Dec; 100(3):172-84. PubMed ID: 17126803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major.
    Ong HB; Sienkiewicz N; Wyllie S; Fairlamb AH
    J Biol Chem; 2011 Mar; 286(12):10429-38. PubMed ID: 21239486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitors.
    Florence GJ; Fraser AL; Gould ER; King EF; Menzies SK; Morris JC; Tulloch LB; Smith TK
    ChemMedChem; 2014 Nov; 9(11):2548-56. PubMed ID: 25145275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-resolution crystal structure of Trypanosoma brucei UDP-galactose 4'-epimerase: a potential target for structure-based development of novel trypanocides.
    Shaw MP; Bond CS; Roper JR; Gourley DG; Ferguson MA; Hunter WN
    Mol Biochem Parasitol; 2003 Feb; 126(2):173-80. PubMed ID: 12615316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
    Ferrari S; Morandi F; Motiejunas D; Nerini E; Henrich S; Luciani R; Venturelli A; Lazzari S; Calò S; Gupta S; Hannaert V; Michels PA; Wade RC; Costi MP
    J Med Chem; 2011 Jan; 54(1):211-21. PubMed ID: 21126022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.
    Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
    Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
    Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP
    J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
    De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structures and inhibition of Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase.
    Terán D; Hocková D; Česnek M; Zíková A; Naesens L; Keough DT; Guddat LW
    Sci Rep; 2016 Oct; 6():35894. PubMed ID: 27786284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase.
    Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
    Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
    Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors.
    Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD
    Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.
    Corona P; Gibellini F; Cavalli A; Saxena P; Carta A; Loriga M; Luciani R; Paglietti G; Guerrieri D; Nerini E; Gupta S; Hannaert V; Michels PA; Ferrari S; Costi PM
    J Med Chem; 2012 Oct; 55(19):8318-29. PubMed ID: 22946585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.